The market in India for in vitro diagnostics (IVDs)—the simple but effective laboratory tests on tissue samples used to detect diseases, conditions, and infections—is growing by a rapid 8.6% annually,... Read More
...PET equipment. It is the latest move by India to implement a 2017 law that established regulations on the medical device industry. Previously, the medical device industry in India was... Read More
Beginning November 1, 2018, high-risk medicines sold in India will be required to carry warnings on the packaging, part of a series of moves by the country’s Ministry of Health... Read More
In March 2018, India’s Department of Pharmaceuticals published guidelines proposing that domestic-made components make up 25 to 50 percent of medical devices procured by the government. The 25 percent requirement... Read More
Over the last few years, the number of clinical trials in India has dropped by 90%. In March 2018, India’s Health Ministry released a comprehensive set of rules for clinical... Read More
Earlier this year, India’s in vitro diagnostics (IVDs) rules of 2017 went into effect. IVDs are now classified in four classes: A, B, C, and D. The 2017 rules have... Read More
...of rising political pressure in India to make healthcare more affordable. Earlier in 2017, the Indian government capped the price of knee implants and cardiac stents. A lobby group of... Read More
India’s government will release a Uniform Code for Medical Device Marketing Practice (UCMDMP) as it prepares to implement new regulations in January 2018. Medical devices in India have been regulated... Read More
India has issued new caps on the prices of 51 essential drugs in a move expected to reduce prices by between 6% and 53%, according to The Economic Times. Drugs... Read More
The Indian Central Drugs Standard Control Organization (CDSCO) has made it mandatory for global drug clinical trials to include Indian patients for internationally developed drugs. Additionally, global clinical trials that... Read More